1. Home
  2. OLMA vs LMNR Comparison

OLMA vs LMNR Comparison

Compare OLMA & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • LMNR
  • Stock Information
  • Founded
  • OLMA 2006
  • LMNR 1893
  • Country
  • OLMA United States
  • LMNR United States
  • Employees
  • OLMA 88
  • LMNR N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • LMNR Farming/Seeds/Milling
  • Sector
  • OLMA Health Care
  • LMNR Consumer Staples
  • Exchange
  • OLMA Nasdaq
  • LMNR Nasdaq
  • Market Cap
  • OLMA 465.4M
  • LMNR 486.1M
  • IPO Year
  • OLMA 2020
  • LMNR N/A
  • Fundamental
  • Price
  • OLMA $5.92
  • LMNR $26.60
  • Analyst Decision
  • OLMA Strong Buy
  • LMNR Buy
  • Analyst Count
  • OLMA 5
  • LMNR 2
  • Target Price
  • OLMA $26.25
  • LMNR $24.00
  • AVG Volume (30 Days)
  • OLMA 1.0M
  • LMNR 36.6K
  • Earning Date
  • OLMA 11-12-2024
  • LMNR 12-23-2024
  • Dividend Yield
  • OLMA N/A
  • LMNR 1.12%
  • EPS Growth
  • OLMA N/A
  • LMNR N/A
  • EPS
  • OLMA N/A
  • LMNR 0.29
  • Revenue
  • OLMA N/A
  • LMNR $189,075,000.00
  • Revenue This Year
  • OLMA N/A
  • LMNR $7.75
  • Revenue Next Year
  • OLMA N/A
  • LMNR $16.50
  • P/E Ratio
  • OLMA N/A
  • LMNR $91.28
  • Revenue Growth
  • OLMA N/A
  • LMNR 6.15
  • 52 Week Low
  • OLMA $6.10
  • LMNR $17.37
  • 52 Week High
  • OLMA $16.78
  • LMNR $29.22
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 23.84
  • LMNR 48.39
  • Support Level
  • OLMA $6.25
  • LMNR $26.47
  • Resistance Level
  • OLMA $6.87
  • LMNR $27.42
  • Average True Range (ATR)
  • OLMA 0.82
  • LMNR 0.73
  • MACD
  • OLMA -0.34
  • LMNR -0.08
  • Stochastic Oscillator
  • OLMA 0.00
  • LMNR 42.53

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About LMNR Limoneira Co

Limoneira Co is an agribusiness company. The company's operating segments include Fresh Lemons; Lemon Packing; Avocados and Other Agribusiness. It generates maximum revenue from the Fresh Lemons segment.

Share on Social Networks: